Table 1 Clinical characteristics of patients with full-thickness MH caused by laser
From: Vitrectomy for laser-induced full-thickness macular hole
Patient No. | Age | Sex | Laser type | Interval From Injury to Sugery | Preoperative BCVA | Tamponade agent used | MH Size (MD/BD) (μm) | Last follow-up After PPV (months) | BCVA at last follow-up | Post operative OCT |
|---|---|---|---|---|---|---|---|---|---|---|
1* | 39 | M | laserpoint | 2 mo | 20/200 | Air | 606/1042 | 5 wk | 20/100 | Closed |
2 | 16 | M | laserpoint | 6 mo | 20/100 | Air | 358/982 | 11 mo | 20/67 | Closed; |
3* | 17 | F | laserpoint | 1 mo | 20/167 | Air | 601/969 | 13 mo | 20/50 | Closed; |
4* | 25 | F | laserpoint | 2 mo | 20/250 | Air | 966/2255 | 6 mo | 20/200 | Closed; destroyed RPE |
5 | 23 | M | Laserpoint | 12 mo | 20/50 | C3F8 | 55/826 | 2 mo | 20/25 | Closed |
6 | 13 | M | laserpoint | 4 mo | 20/167 | C3F8 | 857/2020 | 2 mo | 20/40 | Closed |
7 | 25 | M | Nd:YAG | 3 wk | 20/200 | Air | 823/1228 | 1 mo | 20/100 | Closed; destroyed RPE |
8 | 22 | M | Nd:YAG | 3 mo | 20/40 | Air | 294/602 | 3 mo | 20/25 | Closed; |
9* | 33 | M | Nd:YAG | 2 mo | 20/200 | C3F8 | 573/1041 | 54 mo | 20/100 | Closed; destroyed RPE |
10 | 20 | M | Nd:YAG | 8 mo | 20/400 | SF6 | 347/999 | 37 mo | 20/200 | Closed; destroyed RPE |